M. Bolte, C. Strahringer
Jul 1, 1999
Citations
0
Influential Citations
1
Citations
Journal
Journal of Chemical Crystallography
Abstract
The crystal structures of (1R,5R,8S)-8-[(2R,4R)-4-ethyl-3-(2,4,6- trimethyl-benzenesulfonyl)-oxazolidin-2-yl]-1-hydroxy-bicyclo[3.3.1]nonan-3-one (1), formic acid (1S,2R)-2-{2-[(2R,4R)-4-ethyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-cyclohexylidene}-1-trimethylsilanyl-ethyl ester (2), (2R,4R)-2-{(4S,5R,6S)-6-tertbutyl-2,2,4,5-tetramethyl-[1,3]dioxan-4-yl}-4-ethyl-3-(toluene-4-sulfonyl)-oxazolidine (3), (2S)-2-[(2R,4R,5R)-4-methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-3,4-dihydro-2H-naphthalen-1-one (4) and (1R)-1-[(2R,4R,5R)-4-methyl-5-phenyl-3-(toluene-4-sulfonyl)-oxazolidin-2-yl]-3,4-dihydro-1H-naphthalen-2-one (5) have been determined: (1) crystallizes in the orthorhombic space group P212121 with cell dimensions a = 11.120(1), b = 13.809(1), c = 14.676(1) Å, (2) crystallizes in the monoclinic space group P21 with cell dimensions a = 12.577(3), b = 9.589(1), c = 13.971(3) Å, β = 95.77(1) °, (3) crystallizes in the monoclinic space group P21 with cell dimensions a = 7.990(4), b = 11.282(9), c = 14.473(4) Å, β = 96.31(3)°, (4) crystallizes in the orthorhombic space group P212121 with cell dimensions a = 7.674(1), b = 14.647(1), c = 20.620(1) Å, (5) crystallizes in the monoclinic space group P21 with cell dimensions a = 7.890(2), b = 11.319(1), c = 13.493(3) Å, β = 104.12(1)°.